Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
Clinical trial NCT05687110 · RECRUITING
Trial details
- NCT number
- NCT05687110
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-06
- Primary completion
- 2028-07-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.